Join Dr. Ted Feldman, Chief Medical Officer at Rightway, and Kristin Devlin, Senior VP of Pharmacy, as they unpack GLP-1 drugs — a groundbreaking class of medicines reshaping treatment for diabetes, obesity, and cardiometabolic disease. In this episode, they explain: How GLP-1s work and why they’re generating so much attention. Who may benefit most from these therapies. Practical considerations like safety, access, and adherence. How Rightway supports members with benefit navigation, manufacturer programs, and cost-saving strategies.